Table 1. Association of UCHL5 with clinicopathological variables in gastric cancer patients.
| UCHL5 | |||
|---|---|---|---|
| Negative | Positive | ||
| n (%) | 111 (22.7) | 379 (77.3) | p value |
| Age, years | |||
| <66 | 51 (22.0) | 181 (78.0) | 0.747 |
| ≥66 | 60 (23.3) | 198 (76.7) | |
| Gender | |||
| Male | 54 (22.3) | 188 (77.7) | 0.914 |
| Female | 57 (23.0) | 191 (77.0) | |
| TNM stage | |||
| IA-IB | 21 (20.8) | 80 (79.2) | 0.619 |
| II | 19 (21.3) | 70 (78.7) | |
| IIIA-IIIC | 41 (24.6) | 126 (75.4) | |
| IV | 30 (22.7) | 102 (77.3) | |
| Unavailable data | 1 | ||
| pT-classification | |||
| pT1 | 16 (22.5) | 55 (77.5) | 0.560 |
| pT2 | 16 (21.9) | 57 (78.1) | |
| pT3 | 39 (20.4) | 152 (79.6) | |
| pT4 | 40 (25.8) | 115 (74.2) | |
| pN-classification | |||
| pN0 | 35 (20.5) | 136 (79.5) | 0.567 |
| pN+ | 71 (22.9) | 239 (77.1) | |
| Unavailable data | 5 | 4 | |
| pM-classification | |||
| pM0 | 83 (22.9) | 279 (77.1) | 0.902 |
| pM1 | 28 (21.9) | 100 (78.1) | |
| Laurén classification | |||
| Intestinal | 34 (16.3) | 175 (83.7) | 0.004 |
| Diffuse | 75 (27.5) | 198 (72.5) | |
| Unavailable data | 2 | 6 | |
| Tumor size, cm | |||
| <5 | 46 (26.0) | 131 (74.0) | 0.173 |
| ≥5 | 61 (20.3) | 240 (79.7) | |
| Unavailable data | 4 | 8 | |
Abbreviations: UCHL5 = ubiquitin C-terminal hydrolase L5; Unavailable data: number of patients lacking the subgroup characteristic.